Wednesday, 9 June 2021

Bharat Biotech Expects Peer Review of Covaxin's Phase 3 Trials Data in Q4 2021

Bharat Biotech said there were nine publications on Covaxin so far and the efficacy paper of phase-3 trials would be the tenth one.

from Top Business News- News18.com https://ift.tt/3ze702a
via IFTTT

No comments:

Post a Comment

Beyond Borders: The True Origins Of India's Favorite Brands - Colgate, Bata And Maruti

Bata grew into one of the world's leading shoemakers, with an impressive annual sale of 150 million pairs of shoes across more than 70 c...